Drug application
IRON SUCROSE (IRON SUCROSE)
Drugs@FDA ANDA 212559 · MYLAN LABS LTD
Key facts
| Drug name | IRON SUCROSE |
|---|---|
| Active ingredients | IRON SUCROSE |
| Application type | ANDA |
| Application number | 212559 |
| Company | MYLAN LABS LTD |
| Dosage forms | INJECTABLE, INTRAVENOUS |
| Strength | EQ 50MG IRON/2.5ML (EQ 20MG IRON/ML) |
| Marketing status | Discontinued |
| TE codes | AB |
| Reference listed drug | No |
| Latest submission status date | Aug 8, 2025 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.